Menu
Enrolling by invitation NCT07501624

Engaging Pharmacists to Advance Tobacco Treatment Service Delivery

No phase Interventional Smoking Cessation Tobacco Use Disorder Smoking HIV

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: ENgaging pHarmacists to AdvANCE Tobacco Treatment Service delivery (ENHANCE-TTS).
Who it may be relevant to
Registry conditions: Smoking Cessation, Tobacco Use Disorder, Smoking, HIV. Basic parameters: from 21 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Engaging Pharmacists to Advance Tobacco Treatment Service Delivery for People Living With HIV

Overview

This research will test the effects of a novel program (ENHANCE-TTS) with tools, training, and clinic facilitation support that capitalizes on pharmacists' roles by expanding their scope of practice to deliver tobacco treatment. This effectiveness-implementation study will evaluate the effects of the ENHANCE-TTS program on implementation outcomes and patient-level smoking cessation outcomes in people living with HIV and concurrently identify key barriers and facilitators to implementing this program in practice.

Detailed description

The overall goal of this research is to improve care for people living with HIV through the delivery of high-quality tobacco treatment to address the high rates of smoking in this population. This research will test the effects of a novel program on pharmacists' roles by expanding their scope of practice to deliver tobacco treatment. Investigators will evaluate provider- and patient-level outcomes.

Interventions

  • Behavioral ENgaging pHarmacists to AdvANCE Tobacco Treatment Service delivery (ENHANCE-TTS)
    The ENHANCE-TTS program includes team-building at each clinic, pharmacist training, facilitation (i.e., infrastructure planning for systems change, problem-solving, and coaching) and tools (clinic roadmap, readiness assessment, training workbook).

Primary outcome measures

  • Adoption of the Intervention [Time frame: From baseline clinic engagement to 12 months following program launch]
  • Acceptability of the Intervention [Time frame: 3-Month Implementation Period]
  • Fidelity to the Intervention [Time frame: Implementation Period Through Study Completion (approximately 4 year study period)]
  • Cost to Implement the Intervention [Time frame: 3-Month Implementation Period]
  • Penetration of the Intervention [Time frame: From Study Start (Pre-Implementation Period) to Study Completion (Post-Implementation Period) (approximately 4 year study period)]
Secondary outcome measures (1)
  • Smoking Abstinence [Time frame: 3- and 6-month follow-up]

Eligibility criteria

Pharmacist, Clinic Administrator, and Patient Advocate inclusion criteria:

Pharmacists, Clinic Administrators, and Patient Advocates from each of 6 Ryan White clinics who agree to participate in the study.

Clinic patient inclusion criteria:

  • age 21 and older
  • current diagnosis of HIV
  • completed at least 1 visit with the clinical pharmacist for tobacco treatment, 4) English speaking;

Exclusion:

1\) currently imprisoned.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Sequential
Masking
Open label
Primary purpose
Health services research

Study locations

United States · 1 center
  • Medical University of South Carolina — Charleston

Identifiers

NCT: NCT07501624 · Pro00142041

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗